Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael H Charlton

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Cheminformatics|June 9, 2016
Are the physicochemical properties of antibacterial compounds really different from other drugs?Jean-Paul Ebejer, Michael H Charlton, Paul W Finn
Organic & Biomolecular Chemistry|October 8, 2005
Structure-activity relationships in 3-isothiazolonesJohn O Morley, A Jayne Oliver Kapur, Michael H Charlton
Combinatorial Chemistry & High Throughput Screening|August 24, 2004
The selection and design of GPCR ligands: from concept to the clinicMark Ashton, Michael H Charlton, Matthias K Schwarz, et al.
Plos One|December 15, 2015
Comparison of the Structure and Activity of Glycosylated and Aglycosylated Human Carboxylesterase 1Victoria Arena de Souza, David J Scott, Joanne E Nettleship, et al.
Bioorganic & Medicinal Chemistry Letters|January 16, 2009
Discovery of novel inhibitors of Trypanosoma cruzi trans-sialidase from in silico screeningJoão Neres, Mark L Brewer, Laura Ratier, et al.
ACS Medicinal Chemistry Letters|February 20, 2018
<i>N</i>-Leucinyl Benzenesulfonamides as Structurally Simplified Leucyl-tRNA Synthetase InhibitorsMichael H Charlton, Rihards Aleksis, Adélaïde Saint-Leger, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 23, 2011
Drug targeting to monocytes and macrophages using esterase-sensitive chemical motifsLindsey A Needham, Alan H Davidson, Lindsay J Bawden, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Cheminformatics|June 9, 2016
Are the physicochemical properties of antibacterial compounds really different from other drugs?Jean-Paul Ebejer, Michael H Charlton, Paul W Finn
Organic & Biomolecular Chemistry|October 8, 2005
Structure-activity relationships in 3-isothiazolonesJohn O Morley, A Jayne Oliver Kapur, Michael H Charlton
Combinatorial Chemistry & High Throughput Screening|August 24, 2004
The selection and design of GPCR ligands: from concept to the clinicMark Ashton, Michael H Charlton, Matthias K Schwarz, et al.
Plos One|December 15, 2015
Comparison of the Structure and Activity of Glycosylated and Aglycosylated Human Carboxylesterase 1Victoria Arena de Souza, David J Scott, Joanne E Nettleship, et al.
Bioorganic & Medicinal Chemistry Letters|January 16, 2009
Discovery of novel inhibitors of Trypanosoma cruzi trans-sialidase from in silico screeningJoão Neres, Mark L Brewer, Laura Ratier, et al.
ACS Medicinal Chemistry Letters|February 20, 2018
<i>N</i>-Leucinyl Benzenesulfonamides as Structurally Simplified Leucyl-tRNA Synthetase InhibitorsMichael H Charlton, Rihards Aleksis, Adélaïde Saint-Leger, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 23, 2011
Drug targeting to monocytes and macrophages using esterase-sensitive chemical motifsLindsey A Needham, Alan H Davidson, Lindsay J Bawden, et al.
Pageof 1